Format

Send to

Choose Destination
Am J Infect Control. 2014 Feb;42(2):206-8. doi: 10.1016/j.ajic.2013.09.003.

Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes.

Author information

1
Department of Chest Diseases, Mersin University School of Medicine, Mersin, Turkey.
2
Department of Infection Disease, Mersin University School of Medicine, Mersin, Turkey. Electronic address: sahinelif@gmail.com.
3
Department of Cardiovascular Surgery, Mersin University School of Medicine, Mersin, Turkey.
4
Department of Infection Disease, Mersin University School of Medicine, Mersin, Turkey.

Abstract

Acinetobacter baumannii is characterized by a rapid development of resistance to the commonly used antimicrobial agents. We investigated the risk factors, clinical features, and outcomes in ventilator-associated pneumonia (VAP) caused by extensive drug-resistant Acinetobacter baumannii (XDRAB). Clinical parameters and overall in-hospital mortality rates were compared between the VAP with and without XDRAB infection groups. This study showed that VAP caused by XDRAB was not associated with in-hospital mortality. However, it was related to high Simplified Acute Physiology Score II scores and increasing durations of hospital stays.

KEYWORDS:

Acinetobacter baumannii; Outcome; SAPS II; Simplified Acute Physiology Score II; Ventilator-associated pneumonia

PMID:
24485378
DOI:
10.1016/j.ajic.2013.09.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center